GB201707955D0 - Dual amylin and calcitonin receptor agonists for treating diseases and disorders - Google Patents

Dual amylin and calcitonin receptor agonists for treating diseases and disorders

Info

Publication number
GB201707955D0
GB201707955D0 GBGB1707955.9A GB201707955A GB201707955D0 GB 201707955 D0 GB201707955 D0 GB 201707955D0 GB 201707955 A GB201707955 A GB 201707955A GB 201707955 D0 GB201707955 D0 GB 201707955D0
Authority
GB
United Kingdom
Prior art keywords
disorders
receptor agonists
treating diseases
calcitonin receptor
amylin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1707955.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KEYBIOSCIENCE AG
Original Assignee
KEYBIOSCIENCE AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KEYBIOSCIENCE AG filed Critical KEYBIOSCIENCE AG
Priority to GBGB1707955.9A priority Critical patent/GB201707955D0/en
Publication of GB201707955D0 publication Critical patent/GB201707955D0/en
Application status is Ceased legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/585Calcitonins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
GBGB1707955.9A 2017-05-18 2017-05-18 Dual amylin and calcitonin receptor agonists for treating diseases and disorders Ceased GB201707955D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1707955.9A GB201707955D0 (en) 2017-05-18 2017-05-18 Dual amylin and calcitonin receptor agonists for treating diseases and disorders

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1707955.9A GB201707955D0 (en) 2017-05-18 2017-05-18 Dual amylin and calcitonin receptor agonists for treating diseases and disorders
PCT/EP2018/063202 WO2018211111A1 (en) 2017-05-18 2018-05-18 Dual amylin and calcitonin receptor agonists for treating diseases and disorders

Publications (1)

Publication Number Publication Date
GB201707955D0 true GB201707955D0 (en) 2017-07-05

Family

ID=59220532

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1707955.9A Ceased GB201707955D0 (en) 2017-05-18 2017-05-18 Dual amylin and calcitonin receptor agonists for treating diseases and disorders

Country Status (2)

Country Link
GB (1) GB201707955D0 (en)
WO (1) WO2018211111A1 (en)

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708934A (en) 1984-09-27 1987-11-24 Unigene Laboratories, Inc. α-amidation enzyme
US5789234A (en) 1987-08-14 1998-08-04 Unigene Laboratories, Inc. Expression systems for amidating enzyme
US6319685B1 (en) 1984-09-27 2001-11-20 Unigene Laboratories, Inc. Alpha-amidating enzyme compositions and processes for their production and use
US5102666A (en) 1990-09-11 1992-04-07 Oramed, Inc. Calcium polycarbophil controlled release composition and method
US5359030A (en) 1993-05-10 1994-10-25 Protein Delivery, Inc. Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
US6692766B1 (en) 1994-06-15 2004-02-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Controlled release oral drug delivery system
US5866536A (en) 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
US5773647A (en) 1997-02-07 1998-06-30 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
DK2088188T3 (en) 1997-04-16 2012-01-02 Unigene Lab Inc Direct expression of peptides in culture media
WO2000033866A1 (en) 1998-12-04 2000-06-15 Provalis Uk Limited Pharmaceutical compositions containing insulin
IL145546D0 (en) 1999-04-05 2002-06-30 Emisphere Tech Inc Disodium salts, monohydrates, and ethanol solvates for delivering active agents
US6780846B1 (en) 1999-09-27 2004-08-24 Elan Corporation, Plc Membrane translocating peptide drug delivery system
GB2368792A (en) 2000-10-06 2002-05-15 Roger Randal Charles New Absorption enhancers
US6673574B2 (en) 2000-11-30 2004-01-06 Unigene Laboratories Inc. Oral delivery of peptides using enzyme-cleavable membrane translocators
US7316819B2 (en) 2001-03-08 2008-01-08 Unigene Laboratories, Inc. Oral peptide pharmaceutical dosage form and method of production
US6770625B2 (en) 2001-09-07 2004-08-03 Nobex Corporation Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
EP1670500A2 (en) 2003-09-17 2006-06-21 Chiasma, Ltd. Compositions capable of facilitating penetration across a biological barrier
CA2520660C (en) 2003-03-28 2013-08-20 Sigmoid Biotechnologies Limited Solid oral dosage form containing seamless microcapsules
GB0308732D0 (en) 2003-04-15 2003-05-21 Axcess Ltd Absorption enhancers
PT1651249E (en) 2003-07-23 2012-12-21 Novartis Ag Use of calcitonin in osteoarthritis
AU2005263729B2 (en) 2004-07-22 2011-01-06 Bey Pharma GmbH Use of compounds containing thiol groups as an efflux pump inhibitor
US7445911B2 (en) 2004-11-24 2008-11-04 Unigene Laboratories Inc. Enzymatic reactions in the presence of keto acids
CA2613471C (en) 2005-06-24 2016-09-06 Unigene Laboratories, Inc. Cell lines for expressing enzyme useful in the preparation of amidated products
EP1933862B1 (en) 2005-09-06 2014-03-26 Oramed Pharmaceuticals Inc. Methods and compositions for oral administration of proteins
US8093207B2 (en) 2005-12-09 2012-01-10 Unigene Laboratories, Inc. Fast-acting oral peptide pharmaceutical products
EP1834635B1 (en) 2006-03-13 2011-07-06 Advanced in Vitro Cell Technologies, S.L. Stable nanocapsule systems for the administration of active molecules
ES2426445T3 (en) 2006-04-07 2013-10-23 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US8377863B2 (en) 2007-05-29 2013-02-19 Unigene Laboratories Inc. Peptide pharmaceutical for oral delivery
US8962015B2 (en) 2007-09-28 2015-02-24 Sdg, Inc. Orally bioavailable lipid-based constructs
AU2012332265B2 (en) 2011-11-02 2016-11-10 Keybioscience Ag Peptide analogs for treating diseases and disorders
SI3068796T1 (en) 2013-11-14 2018-05-31 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
GB201500263D0 (en) * 2015-01-08 2015-02-25 Keybioscience Ag Calcitonin analogues for treating diseases and disorders

Also Published As

Publication number Publication date
WO2018211111A1 (en) 2018-11-22

Similar Documents

Publication Publication Date Title
ZA201802203B (en) Blockchain-based identity and transaction platform
SG11201707192XA (en) Therapeutic antibodies and their uses
WO2015136016A3 (en) Therapeutic combinations with estrogen receptor modulators
ZA201607850B (en) Apelin receptor (apj) agonists and uses thereof
SG11201607522YA (en) Peptidic dual glp-1 / glucagon receptor agonists derived from exendin-4
IL255459D0 (en) Triazole agonists of the apj receptor
SG11201610432UA (en) Formulated receptor polypeptides and related methods
IL248013D0 (en) Dual glp-1/glucagon receptor agonists derived from exendin-4
IL248732D0 (en) Compounds for treating ophthalmic diseases and disorders
DK3242890T3 (en) Agonistic tnf receptor binding agents
HK1219661A1 (en) Use of agonists of formyl peptide receptor for treating dermatological diseases
IL256175D0 (en) Use of exosomes for the treatment of disease
EP3337481A4 (en) Human tlr8-selective agonists
SG11201803417WA (en) Prosthetic valve delivery apparatus having clutch mechanism
ZA201807731B (en) Spiro-lactam nmda receptor modulators and uses thereof
ZA201700342B (en) Novel glp-1 receptor modulators
IL251741D0 (en) Co-agonists of the glucagon and glp-1 receptors
IL259791D0 (en) Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists
IL258092D0 (en) Glucagon receptor agonists
EP3350165A4 (en) Farnesoid x receptor agonists and uses thereof
EP3169260A4 (en) Methods and systems for treating diabetes and related diseases and disorders
IL259947D0 (en) Heteroarylhydroxypyrimidinones as agonists of the apj receptor
IL253271D0 (en) Lingo-1 antagonists and uses for treatment of demyelinating disorders
HUE037663T2 (en) Calcitonin mimetics for treating diseases and disorders
IL258448D0 (en) Antigen-binding proteins that activate the leptin receptor

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)